BARINTHUS BIOTHERAPEUTICS PLC Retained Earnings
BARINTHUS BIOTHERAPEUTICS PLC (BRNS) had Retained Earnings of -$320.21 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-06
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$320.21M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$309.63M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$304.09M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$293.00M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2026-06-30 | -$320.21M 10-Q · filed 2026-08-06 |
| 2026-03-31 | -$309.63M 10-Q · filed 2026-04-30 |
| 2025-12-31 | -$304.09M 10-Q · filed 2026-08-06 |
| 2025-09-30 | -$293.00M 10-Q · filed 2025-11-07 |
| 2025-06-30 | -$278.44M 10-Q · filed 2025-08-07 |
| 2025-03-31 | -$257.31M 10-Q · filed 2025-05-07 |
| 2024-12-31 | -$237.66M 10-K · filed 2026-03-13 |
| 2024-09-30 | -$217.12M 10-Q · filed 2024-11-06 |
| 2024-06-30 | -$209.01M 10-Q · filed 2024-08-08 |
| 2024-03-31 | -$192.08M 10-Q · filed 2024-05-13 |
| 2023-12-31 | -$176.59M 10-K · filed 2025-03-20 |
| 2023-09-30 | -$159.30M 10-Q · filed 2023-11-09 |
| 2023-06-30 | -$145.22M 10-Q · filed 2023-08-10 |
| 2023-03-31 | -$121.42M 10-Q · filed 2023-05-12 |
| 2022-12-31 | -$103.24M 10-K · filed 2024-03-20 |
| 2022-09-30 | -$82.05M 10-Q · filed 2022-11-10 |
| 2022-06-30 | -$90.30M 10-Q · filed 2022-08-09 |
| 2022-03-31 | -$105.99M 10-Q · filed 2022-05-11 |
| 2021-12-31 | -$108.58M 10-K · filed 2023-03-24 |
| 2021-09-30 | -$93.47M 10-Q · filed 2021-11-12 |
| 2021-06-30 | -$88.92M 10-Q · filed 2021-08-12 |
| 2021-03-31 | -$72.99M 10-Q · filed 2021-06-14 |
| 2020-12-31 | -$57.72M 10-K · filed 2022-03-25 |